William Messer

15PUBLICATIONS
86CO-AUTHORS
VenereologyMedical virologyHorticultural crop protection (incl. pests, diseases and weeds)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 05, 2026
Virus reactivation in acute and long COVID-19.

|Mar 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Abigail Glascock, Cole Maguire, Hoang Van Phan

|Feb 11, 2026
New Insights Into an Old Vaccine: Potency and Breadth of Neutralizing Antibodies Elicited by Yellow Fever Vaccine 17D Are Boosted by Heterologous Orthoflavivirus Infection.

Felicity J Coulter, Courtney A Micheletti, Abram E Estrada

|Jan 03, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Aug 06, 2025
New insights into an old vaccine: potency and breadth of neutralizing antibodies elicited by the yellow fever vaccine 17D are boosted by heterologous Orthoflavivirus infection.

Felicity J Coulter, Abram E Estrada, Courtney A Micheletti

|Jun 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

Charles Langelier, Abigail Glascock, Cole Maguire

Pageof 3

Frequent Collaborators

8 joint publications

Al Ozonoff

8 joint publications

Ofer Levy

7 joint publications

Florian Krammer

7 joint publications

Charles R Langelier